| Cytos to Secure up to CHF 37M to Advance Phase II Asthma Immunotherapy Genetic Engineering News This approach modifies the patient's immunological response to allergens and has the potential to alter asthma therapy dramatically, Cytos says. The firm will also use the funds to develop additional pipeline programs and progress its Immunodrug ... See all stories on this topic » | ||
| ||
| Winter ends with record pollen count Walton Tribune ... and hospital emergency room visits increase due to the uptick in asthma and difficulty breathing. The average resident is merely annoyed and inconvenienced by the pollen." Miller said dealing with pollen could involve a variety of treatments. See all stories on this topic » |
Wednesday, March 21, 2012
Asthma treatment
Labels:
asthma treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment